FL20 G Pill — GREEN;PURPLE CAPSULE, 16mm — Fluoxetine
| Imprint | FL20 / G |
|---|---|
| Colour | GREEN;PURPLE |
| Shape | CAPSULE |
| Size | 16 |
| Strength | — |
| Dosage form | Capsule |
| Manufacturer | Alphapharm Pty Ltd |
| NDC | 57315-032 |
| Schedule | — |
| Availability | — |
| Ingredients | — |
What does this imprint mean?
The imprint "FL20 G" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.
Active ingredient
Fluoxetine
Uses and warnings
BOXED WARNING: BOXED WARNING - Suicidal Thoughts and Behaviors: "Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies." Monitoring is required for all ages starting antidepressant therapy. "Fluoxetine is not approved for use in children less than 7 years of age." Key Warnings Include: - Serotonin syndrome risk when combined with other serotonergic drugs - Allergic reactions and rash (discontinue if occurs) - Activation of mania/hypomania in bipolar patients - Seizure risk in predisposed individuals - Weight loss and appetite changes - Abnormal bleeding (especially with NSAIDs/warfarin) - Angle-closure glaucoma in susceptible patients - Hyponatremia/SIADH - QT interval prolongation - Cognitive and motor impairment potential --- | BOXED WARNING - Suicidal Thoughts and Behaviors: "Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies." Monitoring is required for all ages starting antidepressant therapy. "Fluoxetine is not approved for use in children less than 7 years of age." Key Warnings Include: - Serotonin syndrome risk when combined with other serotonergic drugs - Allergic reactions and rash (discontinue if occurs) - Activation of mania/hypomania in bipolar patients - Seizure risk in predisposed individuals - Weight loss and appetite changes - Abnormal bleeding (especially with NSAIDs/warfarin) - Angle-closure glauc
Fluoxetine is indicated for: - "Acute and maintenance treatment of Major Depressive Disorder" - "Acute and maintenance treatment of obsessions and compulsions in patients with Obsessive Compulsive Disorder (OCD)" - "Acute and maintenance treatment of binge-eating and vomiting behaviors in patients with moderate to severe Bulimia Nervosa" - "Acute treatment of Panic Disorder, with or without agoraphobia" ---
How to identify this pill
- • Check the imprint matches exactly: "FL20 G".
- • Confirm the colour (GREEN;PURPLE) and shape (CAPSULE).
- • Compare the size (16) against a ruler if possible.
- • When in doubt, confirm with a pharmacist before taking any medication.
Similar-looking pills
Other pills of Fluoxetine
PLIVA 648
WHITE CAPSULE · Fluoxetine
E 88
GREEN CAPSULE · Fluoxetine
TEVA 5507
RED CAPSULE · Fluoxetine
E 88
GREEN CAPSULE · Fluoxetine
FL 60
WHITE CAPSULE · Fluoxetine
PLIVA 647
WHITE CAPSULE · Fluoxetine
40 A107
BLUE CAPSULE · Fluoxetine
C30
GREEN;ORANGE CAPSULE · Fluoxetine
GG550
WHITE CAPSULE · Fluoxetine
7188 9
BLUE OVAL · Fluoxetine
E 91
GREEN;WHITE CAPSULE · Fluoxetine
4356 20
BLUE CAPSULE · Fluoxetine
Official references
Source: FDA Structured Product Label via NLM Pillbox archive (retired 2021); source file F63868AF-7C5B-430A-81E7-2483286936F1.xml